164 results
Page 7 of 9
8-K
EX-10.2
6p8mase8
2 Jun 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
zfe4dyt
6 May 16
Unregistered Sales of Equity Securities
12:00am
8-K
EX-10.1
o59e9iifpsehhv
9 Sep 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
pgtj02oe62
31 Jul 15
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.3
66oan
6 Jul 15
Arch Therapeutics Announces Private Placement
12:00am
8-K
EX-10.2
dxa159
6 Jul 15
Arch Therapeutics Announces Private Placement
12:00am
8-K
EX-10.1
pa1 uyzomb
6 Jul 15
Arch Therapeutics Announces Private Placement
12:00am
8-K
EX-10.1
i5800neqtkk knsb
23 Jun 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
j66hit442b1 a8hjedh3
1 Jun 15
Arch Therapeutics Initiates Research and Development Collaboration with CÚRAM Centre for Research in Medical Devices
12:00am
8-K
EX-10.2
w3ndzczv1lhmwa
13 Mar 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
ob2vou48b3hv
13 Mar 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.3
j4h3pj kngij
13 Mar 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
x6omjgy85
2 Dec 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
4fvyg4n72jgcaa
7 Jul 14
Arch Therapeutics Appoints Richard Davis as Chief Financial Officer
12:00am
8-K
EX-10.1
p9upi
27 Mar 14
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.2
g28x58jplg1 5k22i
27 Mar 14
Departure of Directors or Certain Officers
12:00am